FDx Advisors’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,889
Closed -$258K 711
2023
Q2
$258K Buy
+5,889
New +$272K 0.01% 645
2022
Q3
Sell
-7,774
Closed -$335K 776
2022
Q2
$335K Sell
7,774
-934
-11% -$42.7K 0.01% 588
2022
Q1
$470K Sell
8,708
-1,202
-12% -$61.4K 0.02% 525
2021
Q4
$593K Sell
9,910
-693
-7% -$43.1K 0.02% 485
2021
Q3
$695K Buy
10,603
+505
+5% +$32.8K 0.02% 412
2021
Q2
$638K Buy
10,098
+1,814
+22% +$104K 0.02% 440
2021
Q1
$404K Buy
8,284
+1,417
+21% +$68K 0.02% 526
2020
Q4
$283K Buy
6,867
+1,404
+26% +$64.4K 0.01% 587
2020
Q3
$251K Buy
+5,463
New +$253K 0.01% 529

Other funds holding KIDS

FDx Advisors's KIDS Position: Q3 2023 in Review

FDx Advisors sold out of OrthoPediatrics (KIDS) in Q3 2023, closing a stake of 5,889 shares — an estimated $258K sold.

FDx Advisors first reported a position in KIDS in Q3 2020 and held it in 9 quarters. The position peaked at $695K in Q3 2021. 117 funds tracked by Wall St. Rank hold KIDS as of Q3 2023.

  • FDx Advisors reported no remaining OrthoPediatrics position as of Q3 2023 after selling out during the quarter.
  • FDx Advisors sold 5,889 OrthoPediatrics shares in Q3 2023, an estimated $258K.
  • FDx Advisors first reported a position in OrthoPediatrics in Q3 2020 and held it in 9 quarters.
  • FDx Advisors's OrthoPediatrics position peaked at $695K in Q3 2021.
  • 117 funds tracked by Wall St. Rank held OrthoPediatrics as of Q3 2023.

Based on FDx Advisors's 13F filing for Q3 2023, filed 2 Nov 2023.